» Articles » PMID: 21530816

Allergen Compatibilities in Extract Mixtures

Overview
Date 2011 May 3
PMID 21530816
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Stability studies with a few well-characterized allergen extracts have yielded useful information about the shelf-life of these products stored under various conditions. The development of validated stability-indicating tests and their clinical verification remains a fundamental challenge for extending this information to cover more products. This challenge becomes even greater for evaluations of more complex, multiextract mixtures that are used in clinical practice. Thus, the current approach for developing guidelines for extract expiration dating practices must rely on extrapolations of data obtained from a few well-controlled studies.

Citing Articles

The efficacy assessment of a self-administered immunotherapy protocol.

Schaffer F, Garner L, Ebeling M, Adelglass J, Hulsey T, Naples A Int Forum Allergy Rhinol. 2015; 6(2):148-55.

PMID: 26467843 PMC: 4860610. DOI: 10.1002/alr.21653.


Practical recommendations for mixing allergy immunotherapy extracts.

Daigle B, Rekkerth D Allergy Rhinol (Providence). 2015; 6(1):1-7.

PMID: 25860164 PMC: 4388870. DOI: 10.2500/ar.2015.6.0111.


The safety of self-administered allergen immunotherapy during the buildup and maintenance phases.

Schaffer F, Naples A, Ebeling M, Hulsey T, Garner L Int Forum Allergy Rhinol. 2014; 5(2):149-56.

PMID: 25476041 PMC: 4465093. DOI: 10.1002/alr.21443.


Immunotherapy preparation guidelines, rules, and regulation.

Esch R, Plunkett G Curr Allergy Asthma Rep. 2013; 13(4):406-13.

PMID: 23722699 DOI: 10.1007/s11882-013-0358-8.